1. Home
  2. ACCL vs IXHL Comparison

ACCL vs IXHL Comparison

Compare ACCL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$3.10

Market Cap

57.8M

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
IXHL
Founded
2009
2001
Country
Hong Kong
Australia
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
57.8M
49.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ACCL
IXHL
Price
$3.10
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.0K
12.2M
Earning Date
02-20-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
2.91
N/A
EPS
0.08
N/A
Revenue
$4,888,824.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$35.11
N/A
Revenue Growth
11.91
N/A
52 Week Low
$2.10
$0.08
52 Week High
$5.00
$2.25

Technical Indicators

Market Signals
Indicator
ACCL
IXHL
Relative Strength Index (RSI) N/A 52.15
Support Level N/A $0.35
Resistance Level N/A $0.47
Average True Range (ATR) 0.00 0.03
MACD 0.00 -0.00
Stochastic Oscillator 0.00 48.04

Price Performance

Historical Comparison
ACCL
IXHL

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: